Navigate to
-
Adverse reactions or quality problems experienced with the use of these products may be reported to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail or by fax....
-
9 Comprehensive outcomes reporting Insert Link Learn more about cystic fibrosis We support members navigating their cystic fibrosis (CF) with a holistic, customized approach to care. Tab 1 Holistic...
-
$3,413 Medical Formulary Strategy ensures the most appropriate and clinically effective medical benefit drugs are evaluated with product-preferencing strategies, for all lines of business. When...
-
Connect care for your members with cancer Home Our solutions Specialty drug management IntegratedRx IntegratedRx - Oncology Reducing the risk of major side effects IntegratedRx® streamlines the...
-
Insert Link Explore Medical Pharmacy Solutions Medical Formulary Strategy ensures the most appropriate and clinically effective medical benefit drugs are evaluated with product-preferencing...
-
IntegratedRx – Cystic Fibrosis drives $28,200 in savings annually per utilizing member.¹ Provider has minimal connection to central specialty pharmacy. Footnotes 1 Based on actual claims,...
-
Discover our value-based contracting solution Support your members with hemophilia We deliver the insights you need on member adherence, program performance and much more with our robust reporting...
-
April 14, 2025 Author: Simone Ndujiuba, PharmD, BCOP In the United States, pancreatic cancer is the fourth leading cause of cancer related death.¹ In 2023, approximately 64,050 people were...
-
Concerns about pricing remain prominent, reflecting the continued introduction of high‑cost agents and the expansion of existing therapies into earlier lines of treatment and longer durations of...
-
IntegratedRx®– Cystic Fibrosis streamlines the cystic fibrosis treatment pathway with in-house dispensing and a coordinated care team. Oncology Integration is key Connected physician, member and...
-
Nondiscrimination & Languages Prime Therapeutics (Prime) complies with applicable federal civil rights laws and does not discriminate on the basis of race, color, national origin, age, disability...
-
Tab 1 Holistic support across medical & pharmacy benefit Pharmacy benefit Medical benefit Footnotes 72% Multiple sclerosis is a potentially disabling disease of the brain and spinal cord (central...
-
NCCN Recommendations for use of immunoglobulin² Intervention CAR T BsAbs Other indications Immunoglobulin replacement After CAR T-cell therapy, regular immune globulin infusions based on clinical...
-
GuidedHealth can help you save up to $2 per member per month (PMPM).1 1 Prime internal data, 2024; savings specific to health plan, not employer group Home Our solutions Clinical solutions...
-
Heading Example A paragraph is a self-contained unit of a discourse in writing dealing with a particular point or idea. Paragraphs are usually an expected part of formal writing, used to organize...
-
State homepage CMS approval letter Alaska Minnesota State homepage CMS approval letter Michigan State homepage CMS approval letter New Hampshire Attachment B – Catalogue of NMPI participating...
-
Prime Therapeutics Pharmacy LLC Expires 06/03/2027 Prime Therapeutics Management LLC Expires 08/01/2026 View accreditation Prime Therapeutics Pharmacy LLC Expires 04/18/2028 Tab 1 For your patients...
-
$1 MILLION Contact us to learn more The state estimates they will treat 10 patients with Product X over the next 12 months for a total spend of $10 million. Tie costs to outcomes with VBCs 7,000...
-
Expert Clinical Insights A look into our Expert Clinical Network (ECN) — part of Prime/MRx’s value-based approach to medical and pharmacy benefit management that offers access to more than 175...
-
Over time, technology has significantly contributed to health care advancements. Some of these enhancements are now considered routine components of care and include electronic health record,...
-
Pharmacy Times
PA Sub-Categories: Specialty drugs Prime Article: In the News -
October 1, 2025 publications 2025 Medicaid Pharmacy Trend Report In the 2025 Medicaid Pharmacy trend report, we look back on the last 10 years of Medicaid pharmacy economics, providing data-based...
-
Explore what's trending at Prime Home Read, watch, listen Read PA Sub-Categories Select Example Link Example Link Card Title example August 7, 2024 PA Sub-Categories Select Example Link Example...
-
Looking for something? Patient login Already using Home Delivery by Prime Therapeutics Pharmacy? Log in here Mail Please take our survey and tell us how we're doing. [insert short link or use a...
-
Through our person-centered approach, we help coordinate care across multiple providers for members who are at risk for drug abuse or misuse. Targeted provider outreach 1 Mental illness. (March...
-
Manufacturer contact form Save a copy to your desktop and fill out the details. Access the form Louisiana Department of Health and Hospitals Louisiana Medicaid program Prior Authorization Schedule...
-
Expert staff Tap into our insurance expertise to ensure you get the most from your benefits. Specialized care Get info and help managing your condition from specially trained pharmacists and...
-
If you have external monitors, ensure your new laptop successfully connects to your docking station and functions appropriately. Do this before you pack up and return your old device. If you have a...
-
Tap into our Expert Clinical Network Prime received a request for a nonformulary biologic in a young patient with severe Crohn’s disease, as the provider documented past failures of a biologic on...
-
90-day supply Depending on plan design, you may be able to get a 90-day supply of your medicine for less than three 30-day fills. Registered pharmacists Dedicated pharmacists can help get your meds...
-
Fall 2024 edition provides insights into groundbreaking specialty solutions for managed care
PA Sub-Categories: Specialty drugs Prime Article: Stories -
Recent studies have reported an incidence of TA-TMA spanning from 2% to 39%. Such wide variability is thought to stem from inconsistent diagnostic definitions as well as the inclusion of both...
-
Appetite For Change uses food as a tool to build health, wealth and social change. “For youth experiencing homelessness, the Prime Together Foundation’s donation helps The Bridge for Youth go...
-
References Ma L, Guo H, Zhao Y, et al. Liquid biopsy in cancer: current status, challenges and future prospects. Nature. 2024;9(336). McDowell S. Liquid biopsies: past, present, and future....
-
Researchers share insights on accelerated approvals, health equity in food allergies and legislative impacts on sight of service
PA Sub-Categories: GLP-1 Specialty drugs Technology Prime Article: Perspectives -
Oral selective estrogen receptor degraders Agent Status and key trial data What to watch Elacestrant (Orserdu) Approved in 2023 as the first oral SERD in ESR1-mutant metastatic breast cancer via...
-
Notice of privacy practices Effective Date: January 2026 THIS NOTICE DESCRIBES HOW MEDICAL INFORMATION ABOUT YOU MAY BE USED AND DISCLOSED AND HOW YOU CAN GET ACCESS TO THIS INFORMATION. PLEASE...
-
Education information Biometric information Legally protected classification characteristics We collect this information directly from you when you provide it by applying for a job, accepting a job...
-
Abby Kim, PharmD, BCOP, shares how artificial intelligence and novel screening tools are helping to prevent and detect cancer better and sooner
PA Sub-Categories: Specialty drugs Prime Article: Stories -
Drug Approvals Monthly Update: October 2024 This monthly update of United States (U.S.) Food and Drug Administration (FDA) approvals provides a review of newly approved specialty drugs, new...
Prime Article: Research & Publications PA Research & Publications: Drug Approvals -
Cover image for The state of value-based contracting 2.0 An update on Medicaid payment models and opportunities Prime Therapeutics Value-based contracts (VBCs) are performance-based reimbursement...
Prime Article: Research & Publications PA Research & Publications: White Papers -
cover image for Drug Approvals: December 2024 Critical updates in an ever-changing environment Prime Therapeutics /drug-approvals-december-2024 About Prime Therapeutics Prime Therapeutics logo...
Prime Article: Research & Publications PA Research & Publications: Drug Approvals -
Cover image for Drug approvals Critical updates in an ever-changing environment Prime Therapeutics /drug-approvals-december-2024 About Prime Therapeutics Prime Therapeutics logo Prime Therapeutics...
Prime Article: Research & Publications PA Research & Publications: Drug Approvals -
Becker’s Payer Issues
PA Sub-Categories: Specialty drugs Prime Article: In the News -
Cover image for Summer 2023 Prime Therapeutics Report Gene Therapy Update Prime Therapeutics https://issuu.com/primetherapeutics/docs/2023_pt_summer_report_pdf?fr=xKAE9_zU1NQ Explore the report ...
Prime Article: Research & Publications PA Research & Publications: Prime Therapeutics Report -
Oncology Insights: First-in-class bladder cancer therapy and the Bacillus Calmette-Guérin (BCG) shortage
Prime Article: Research & Publications PA Research & Publications: Oncology Insights -
cover image for Drug Approvals: November 2024 Critical updates in an ever-changing environment Prime Therapeutics /drug-approvals-november-2024 Prime Therapeutics’ Drug Approvals provides an...
Prime Article: Research & Publications PA Research & Publications: Drug Approvals -
Drug Approvals Quarterly Update: October 2024 This wrap-up provides a review of newly approved drugs, recent drug launches, new indications and news of note on drugs in the approval process. Prime...
Prime Article: Research & Publications PA Research & Publications: Drug Approvals -
Cover image for Drug Approvals: February 2025 Monthly update on newly approved specialty and traditional drugs, new indications and first-time generic launches Prime Therapeutics...
Prime Article: Research & Publications PA Research & Publications: Drug Approvals -
Cover image for Drug Approvals: March 2025 Monthly update on newly approved specialty and traditional drugs, new indications and first-time generic launches Prime Therapeutics...
Prime Article: Research & Publications PA Research & Publications: Drug Approvals -
cover image Drug Approvals: April 2025 Monthly update on newly approved specialty and traditional drugs, new indications and first-time generic launches Prime Therapeutics...
Prime Article: Research & Publications PA Research & Publications: Drug Approvals -
Cover image for Drug Approvals: July 2024 Monthly update on newly approved specialty and traditional drugs, new indications and first-time generic launches Prime Therapeutics...
Prime Article: Research & Publications PA Research & Publications: Drug Approvals -
Cover image for Summer 2024 Prime Therapeutics Report Pulmonary arterial hypertension: Exciting new approval and payer impact Prime Therapeutics /2024-summer-prime-therapeutics-report The Prime...
Prime Article: Research & Publications PA Research & Publications: Prime Therapeutics Report -
Cover image This high-level drug overview analyzes medical pharmacy claims across commercial, Medicare and Medicaid populations. Prime Therapeutics /2026-medical-pharmacy-trend-report-part-2 The...
Prime Article: Research & Publications PA Research & Publications: Medical Pharmacy Trend Report -
New continuing education course showcases her expertise in biomarker testing and targeted therapy for EGFR-mutated NSCLC
Prime Article: Perspectives -
Jessica Johnson, clinical consultant at Prime's Special Investigations Unit, shares tips to stay safe when using online pharmacies
Prime Article: Perspectives -
Prime is honored to announce its information technology (IT) department’s Quality Excellence Center (QEC), together with Infosys, received the North American Software Testing Award (NASTA) for Best...
PA Sub-Categories: Technology Prime Article: Stories -
Corporate Equality Index is a prominent benchmarking survey and report measuring corporate policies and practices related to LGBTQ+ workplace equality
PA Sub-Categories: Awards Corporate responsibility Prime Article: Stories -
Specialty Pharmacy Continuum
PA Sub-Categories: Specialty drugs Prime Article: In the News -
Discover the latest trends and emerging strategies to manage rising medical benefit specialty drug spend.
PA Sub-Categories: Specialty drugs Prime Article: Press Releases